Medicon Hellas S.A.'s latest marketcap:
As of 07/05/2025, Medicon Hellas S.A.'s market capitalization has reached $12.39 M. According to our data, Medicon Hellas S.A. is the 39207th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 12.39 M |
| Revenue (ttm) | 21.34 M |
| Net Income (ttm) | 1.61 M |
| Shares Out | 4.42 M |
| EPS (ttm) | 0.36 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 07/04/2025 |
| Earnings Date | 07/30/2025 |
Medicon Hellas S.A.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | €12.39 M | 10.19% | 39207 |
| 12/31/2024 | €9.55 M | -35.14% | 38048 |
| 12/29/2023 | €14.72 M | -10% | 34825 |
| 12/30/2022 | €16.35 M | -24.18% | 33344 |
| 12/31/2021 | €21.57 M | 156.84% | 31701 |
| 12/31/2020 | €8.4 M | -20.17% | 32071 |
| 12/31/2019 | €10.52 M | 106.96% | 28352 |
| 12/31/2018 | €5.08 M | 33.72% | 29369 |
| 12/29/2017 | €3.8 M | 177.42% | 29279 |
| 12/30/2016 | €1.37 M | -33.33% | 28591 |
Company Profile
About Medicon Hellas S.A.
Medicon Hellas S.A. is a leading player in the diagnostics industry, providing advanced solutions for healthcare institutions globally. Headquartered in Gerakas, Greece, the company has been serving the medical sector since its incorporation in 1988.
Core Offerings
- Diagnostic Instruments & Tests: Supplies analyzer systems for chemistry, immunochemistry, hematology labs, intensive care units, and point-of-care applications.
- Reagents & Testing Materials: Produces clinical chemistry reagents, control and calibration materials, and specialized tests for various analyzers.
- Cosmetic Products: Develops and markets skincare and cosmetic products under the Miss Beaute brand.
- Healthcare IT Solutions: Designs and sells software for laboratory and medical applications, along with IT systems for healthcare providers.
- Remanufacturing & Services: Offers remanufactured analyzers (chemistry, hematology, blood gas, immunochemistry) and provides contract diagnostics laboratory services.
Global Reach
The company serves public and private hospitals, primary care centers, diagnostic centers, and laboratories across Greece and international markets.
Frequently Asked Questions
-
What is Medicon Hellas S.A.'s (ATH-MEDIC) current market cap?As of 07/05/2025, Medicon Hellas S.A. (including the parent company, if applicable) has an estimated market capitalization of $12.39 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Medicon Hellas S.A. (ATH-MEDIC) rank globally by market cap?Medicon Hellas S.A. global market capitalization ranking is approximately 39207 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.